Can breast cancer patients still have babies after chemo? new study follows 132 women for answers.
NCT ID NCT03795246
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 132 young breast cancer patients who had chemotherapy, with or without a fertility preservation procedure (controlled ovarian hyperstimulation). Researchers track how many become pregnant and give birth over the long term. The goal is to understand how cancer treatment affects future fertility and whether the preservation method helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide clearer information on fertility outcomes after breast cancer treatment, helping patients and doctors make informed decisions about fertility preservation.
- What could go wrong
- This is an observational follow-up study, not a treatment trial. It cannot prove that fertility preservation works for everyone, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 132 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2018
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients included in the study CT 01614704 * Informed and written consent * Affiliated to the National Social Security System Exclusion Criteria: * Impossibility to submit at the study procedures due to geographic, social or mental reasons * Patient deprived of their liberty or under guardianship or tutorship.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Oscar Lambret
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?